Ultrasensitive immunoassay allows measurement of serum neurofilament heavy in multiple sclerosis
Open Access
- 9 February 2021
- journal article
- research article
- Published by Elsevier BV in Multiple Sclerosis and Related Disorders
- Vol. 50, 102840
- https://doi.org/10.1016/j.msard.2021.102840
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosisMultiple Sclerosis Journal, 2019
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in NeurologyJAMA Neurology, 2019
- Neurofilaments as biomarkers in neurological disordersNature Reviews Neurology, 2018
- Multiple sclerosisThe Lancet, 2018
- Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosisAnnals of Neurology, 2017
- Optimizing therapy early in multiple sclerosis: An evidence-based viewMultiple Sclerosis and Related Disorders, 2015
- N-Acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosisZeitschrift für Neurologie, 2014
- A comparative study of CSF neurofilament light and heavy chain protein in MSMultiple Sclerosis Journal, 2013
- Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosisNeurology, 2011
- Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and lossJournal of the Neurological Sciences, 2005